Open Orphan is running some of the world’s first Covid-19 human challenge trials.

Dublin-listed pharmaceutical services company Open Orphan has agreed a new two year contract with one of Europe’s top research-driven pharmaceutical c(...)

Open Orphan executive chairman Cathal Friel

Dublin-listed pharmaceutical services company Open Orphan says it expects to hit profitability in the fourth quarter. The company has been aggressive(...)

Open Orphan executive chairman Cathal Friel: The Paris office has “allowed us to continue to grow the business by winning large, long-term contracts”.

Dublin-listed pharmaceutical services company Open Orphan has secured a long-term contract to support a major European pharmaceutical company. The co(...)

Open Orphan executive chairman Cathal Friel.

Dublin-listed pharmaceutical services company Open Orphan has signed a new deal with New York-based Codagenix for the phase one trial of a new Covid-1(...)

Photograph: iStock

Dublin-listed pharmaceutical services company Open Orphan has signed an option to acquire a company which supports drug trials “for a nominal sum”. (...)

Open Orphan is also working on an antibody testing service that will have capacity for up to 3,000 tests per day. Photograph:   Nicolas Asfouri/AFP

Dublin-listed pharmaceutical services company Open Orphan said it has developed the world’s first challenge study model to test the efficacy of the la(...)

Dublin-listed pharmaceutical services company Open Orphan has signed a deal with an unnamed vaccine developer through its Venn Life Sciences unit. File photograph: Getty

Dublin-listed pharmaceutical services company Open Orphan has signed a deal with an unnamed vaccine developer through its Venn Life Sciences unit. T(...)

Photograph: iStock

Dublin-listed pharmaceutical services company Open Orphan has launched its Covid-19 antibody testing service, supporting the reopening of economies as(...)

Open Orphan will use the funding to advance its antiviral testing capabilities. Photograph: iStock

Dublin-listed pharma services company Open Orphan has raised up to £12 million (€13.4 million) following a conditional offer for shares by technology (...)

A computer image shows a model of a coronavirus. Image: Nexu Science Communication

Dublin-listed pharma services company Open Orphan will have capacity to carry out 3,000 antibody tests per day in the coming weeks as part of efforts (...)

  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • Last »